USM Historical Financial Ratios

USM Stock  USD 60.85  0.18  0.29%   
U S Cellular is promptly reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.86, Dividend Yield of 0.13, PTB Ratio of 0.73 or Days Sales Outstanding of 47.92 will help investors to properly organize and evaluate United States Cellular financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United States Cellular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About USM Financial Ratios Analysis

United States CellularFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate U S Cellular investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on USM financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across U S Cellular history.

U S Cellular Financial Ratios Chart

At this time, U S Cellular's ROIC is very stable compared to the past year. As of the 11th of December 2024, Net Income Per Share is likely to grow to 0.88, while PTB Ratio is likely to drop 0.73.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing United States Cellular stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on U S Cellular sales, a figure that is much harder to manipulate than other United States Cellular multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is United States Cellular dividend as a percentage of U S Cellular stock price. United States Cellular dividend yield is a measure of U S Cellular stock productivity, which can be interpreted as interest rate earned on an U S Cellular investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Revenue Per Share

The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.
Most ratios from U S Cellular's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into United States Cellular current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United States Cellular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At this time, U S Cellular's ROIC is very stable compared to the past year. As of the 11th of December 2024, Net Income Per Share is likely to grow to 0.88, while PTB Ratio is likely to drop 0.73.
 2023 2024 (projected)
PTB Ratio0.760.73
Dividend Yield0.120.13

U S Cellular fundamentals Correlations

-0.691.0-0.11-0.910.11-0.57-0.261.01.00.1-0.83-0.13-0.350.93-0.66-0.11-0.37-0.990.35-0.69-0.63-0.150.89-0.25-0.94
-0.69-0.70.330.67-0.290.20.2-0.7-0.69-0.310.48-0.110.1-0.590.460.180.220.7-0.461.00.590.15-0.630.230.59
1.0-0.7-0.12-0.910.11-0.58-0.271.01.00.1-0.84-0.12-0.350.93-0.66-0.12-0.37-0.990.35-0.69-0.63-0.150.89-0.25-0.94
-0.110.33-0.120.32-0.340.280.33-0.12-0.1-0.260.280.060.12-0.080.180.420.120.06-0.110.33-0.050.01-0.020.260.11
-0.910.67-0.910.32-0.120.750.44-0.91-0.9-0.070.820.010.33-0.860.530.340.250.86-0.280.670.470.07-0.870.380.84
0.11-0.290.11-0.34-0.120.15-0.70.110.10.98-0.150.270.01-0.04-0.06-0.740.31-0.110.08-0.29-0.560.17-0.020.05-0.07
-0.570.2-0.580.280.750.150.51-0.58-0.560.240.770.30.56-0.660.250.390.480.470.210.21-0.07-0.04-0.520.260.64
-0.260.2-0.270.330.44-0.70.51-0.27-0.25-0.640.50.00.35-0.270.020.96-0.010.190.180.20.31-0.25-0.20.040.3
1.0-0.71.0-0.12-0.910.11-0.58-0.271.00.1-0.84-0.12-0.350.93-0.66-0.12-0.37-0.990.35-0.69-0.63-0.150.89-0.25-0.94
1.0-0.691.0-0.1-0.90.1-0.56-0.251.00.1-0.83-0.13-0.350.93-0.66-0.1-0.38-0.990.35-0.69-0.63-0.150.89-0.24-0.94
0.1-0.310.1-0.26-0.070.980.24-0.640.10.1-0.130.260.0-0.05-0.06-0.680.29-0.120.09-0.31-0.620.17-0.030.14-0.08
-0.830.48-0.840.280.82-0.150.770.5-0.84-0.83-0.130.340.75-0.860.470.370.540.770.140.480.35-0.02-0.650.10.94
-0.13-0.11-0.120.060.010.270.30.0-0.12-0.130.260.340.46-0.410.23-0.140.570.080.15-0.12-0.380.32-0.10.050.27
-0.350.1-0.350.120.330.010.560.35-0.35-0.350.00.750.46-0.470.090.290.670.290.610.1-0.03-0.11-0.16-0.30.64
0.93-0.590.93-0.08-0.86-0.04-0.66-0.270.930.93-0.05-0.86-0.41-0.47-0.58-0.1-0.47-0.90.27-0.59-0.42-0.230.88-0.27-0.92
-0.660.46-0.660.180.53-0.060.250.02-0.66-0.66-0.060.470.230.09-0.58-0.160.150.67-0.380.470.360.12-0.740.160.59
-0.110.18-0.120.420.34-0.740.390.96-0.12-0.1-0.680.37-0.140.29-0.1-0.16-0.10.050.20.180.26-0.27-0.030.030.15
-0.370.22-0.370.120.250.310.48-0.01-0.37-0.380.290.540.570.67-0.470.15-0.10.340.210.22-0.060.22-0.15-0.110.54
-0.990.7-0.990.060.86-0.110.470.19-0.99-0.99-0.120.770.080.29-0.90.670.050.34-0.410.70.70.16-0.880.190.92
0.35-0.460.35-0.11-0.280.080.210.180.350.350.090.140.150.610.27-0.380.20.21-0.41-0.47-0.48-0.250.48-0.46-0.06
-0.691.0-0.690.330.67-0.290.210.2-0.69-0.69-0.310.48-0.120.1-0.590.470.180.220.7-0.470.590.15-0.630.240.59
-0.630.59-0.63-0.050.47-0.56-0.070.31-0.63-0.63-0.620.35-0.38-0.03-0.420.360.26-0.060.7-0.480.59-0.07-0.51-0.120.5
-0.150.15-0.150.010.070.17-0.04-0.25-0.15-0.150.17-0.020.32-0.11-0.230.12-0.270.220.16-0.250.15-0.07-0.140.070.09
0.89-0.630.89-0.02-0.87-0.02-0.52-0.20.890.89-0.03-0.65-0.1-0.160.88-0.74-0.03-0.15-0.880.48-0.63-0.51-0.14-0.32-0.78
-0.250.23-0.250.260.380.050.260.04-0.25-0.240.140.10.05-0.3-0.270.160.03-0.110.19-0.460.24-0.120.07-0.320.09
-0.940.59-0.940.110.84-0.070.640.3-0.94-0.94-0.080.940.270.64-0.920.590.150.540.92-0.060.590.50.09-0.780.09
Click cells to compare fundamentals

U S Cellular Account Relationship Matchups

U S Cellular fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio0.821.130.770.650.660.43
Ptb Ratio1.10.740.60.390.760.73
Days Sales Outstanding95.83101.53103.5194.289.5247.92
Book Value Per Share49.0851.5853.1953.9154.7557.49
Free Cash Flow Yield(0.0616)0.0178(0.46)(0.2)0.03630.0381
Operating Cash Flow Per Share8.4214.389.339.7910.1910.7
Stock Based Compensation To Revenue0.01020.0079270.006550.0057570.0058880.004858
Capex To Depreciation1.31.743.021.71.131.62
Pb Ratio1.10.740.60.390.760.73
Ev To Sales1.321.21.531.361.91.8
Free Cash Flow Per Share(2.23)0.55(14.47)(4.18)1.511.58
Roic0.03870.05130.04510.0160.0092850.00975
Inventory Turnover11.0112.2811.037.558.688.25
Net Income Per Share1.482.661.80.350.640.88
Days Of Inventory On Hand33.1429.7233.0948.3342.0325.02
Payables Turnover5.874.635.35.546.973.71
Cash Per Share3.3114.811.813.211.762.01
Pocfratio6.34.32.133.384.083.87
Interest Coverage2.853.392.151.570.710.67
Capex To Operating Cash Flow1.270.962.551.430.851.53
Pfcf Ratio(16.23)56.16(2.18)(4.99)27.5927.62
Days Payables Outstanding62.278.7868.8765.9352.3849.77
Income Quality5.445.315.0123.7714.9315.68
Roe0.03030.05190.03410.0065880.01170.0114
Ev To Operating Cash Flow7.787.343.926.828.568.13
Pe Ratio24.5311.5317.4959.0865.3968.66
Return On Tangible Assets0.02230.03250.02480.0046660.0089150.0152
Ev To Free Cash Flow(27.66)103.2(5.07)(15.99)57.937.91
Earnings Yield0.04080.08680.05720.01690.01530.0189
Net Debt To E B I T D A1.981.923.173.793.673.86
Current Ratio2.13.011.781.441.551.06
Receivables Turnover3.813.593.533.874.087.47
Graham Number40.2755.4346.320.6327.8921.66
Shareholders Equity Per Share48.851.2952.8753.5854.4257.14

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether United States Cellular is a strong investment it is important to analyze U S Cellular's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact U S Cellular's future performance. For an informed investment choice regarding USM Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United States Cellular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of U S Cellular. If investors know USM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about U S Cellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.953
Earnings Share
(0.35)
Revenue Per Share
44.303
Quarterly Revenue Growth
(0.04)
Return On Assets
0.0102
The market value of United States Cellular is measured differently than its book value, which is the value of USM that is recorded on the company's balance sheet. Investors also form their own opinion of U S Cellular's value that differs from its market value or its book value, called intrinsic value, which is U S Cellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because U S Cellular's market value can be influenced by many factors that don't directly affect U S Cellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between U S Cellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if U S Cellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, U S Cellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.